Straumann Holding AG Net Profit Margin 2012-2024 | SAUHY

Current and historical net profit margin for Straumann Holding AG (SAUHY) from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Straumann Holding AG net profit margin for the three months ending December 31, 2024 was .
Straumann Holding AG Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $21.383B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.801B 21.68
Becton Dickinson (BDX) United States $49.503B 12.26
Cardinal Health (CAH) United States $36.644B 19.19
Labcorp Holdings (LH) United States $21.758B 17.65
West Pharmaceutical Services (WST) United States $16.094B 33.74
Cooper (COO) United States $14.283B 18.41
Align Technology (ALGN) United States $13.444B 26.69
Henry Schein (HSIC) United States $8.659B 14.85
Merit Medical Systems (MMSI) United States $5.579B 26.97
DENTSPLY SIRONA (XRAY) United States $3.211B 9.59
CONMED (CNMD) United States $1.762B 13.18
STAAR Surgical (STAA) United States $0.865B 0.00
Lifevantage (LFVN) United States $0.159B 16.43
Pro-Dex (PDEX) United States $0.136B 14.91